132 related articles for article (PubMed ID: 37071766)
1. Synthesis, anticancer activity, molecular docking and molecular dynamics studies of some pyrazole-chalcone hybrids.
Al Otaibi AA; Alshammari SL; Dhahi Alsukaibi AK; Jamal A; Rajendrasozhan S; Alenezi KM; Hussain A; Khan I; Mushtaque M; Haque A
J Biomol Struct Dyn; 2024; 42(3):1381-1391. PubMed ID: 37071766
[TBL] [Abstract][Full Text] [Related]
2. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB
Molecules; 2021 May; 26(10):. PubMed ID: 34064806
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the anticancer mechanism of 1,2,3-triazole-incorporated thiazole-pyrimidine-isoxazoles: insights from docking and molecular dynamics simulations.
Sireesha R; Pavani Y; Mallavarapu BD; Abbasi BA; Guttula PK; Subbarao M
J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38038384
[TBL] [Abstract][Full Text] [Related]
4. Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study.
Bennani FE; Doudach L; Karrouchi K; Tarib A; Rudd CE; Ansar M; Faouzi MEA
J Biomol Struct Dyn; 2023 Jun; 41(9):4194-4218. PubMed ID: 35442150
[TBL] [Abstract][Full Text] [Related]
5. Novel
Haffez H; Elsayed NA; Ahmed MF; Fatahala SS; Khaleel EF; Badi RM; Elkaeed EB; El Hassab MA; Hammad SF; Eldehna WM; Masurier N; El-Haggar R
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2278022. PubMed ID: 37982203
[TBL] [Abstract][Full Text] [Related]
6. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
Murahari M; Prakash KV; Peters GJ; Mayur YC
Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
[TBL] [Abstract][Full Text] [Related]
7. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
8. Visible-light promoted catalyst-free (VLCF) multi-component synthesis of spiro indolo-quinazolinone-pyrrolo[3,4-a]pyrrolizine hybrids: evaluation of
Iqbal S; Farhanaz ; Roohi ; Zaheer MR; Shankar K; Hussain MK; Zia Q; Rehman MT; AlAjmi MF; Gupta A
J Biomol Struct Dyn; 2024 Apr; 42(6):3145-3165. PubMed ID: 37227775
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, anticancer and
Alshammari MM; Soury R; Alenezi KM; Mushtque M; Rizvi MMA; Haque A
J Biomol Struct Dyn; 2022; 40(23):13075-13082. PubMed ID: 34551668
[TBL] [Abstract][Full Text] [Related]
10. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Activity and In Silico ADMET Properties of 2,4,5-Trisubstitutedthiazole Derivatives.
Al-Jaidi BA; Telfah ST; Bardaweel SK; Deb PK; Borah P; Venugopala KN; Bataineh YA; Al Khames Aga QA
Curr Drug Metab; 2021; 22(7):532-536. PubMed ID: 33334285
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
[TBL] [Abstract][Full Text] [Related]
13. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
14. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
Hasan AH; Murugesan S; Amran SI; Chander S; Alanazi MM; Hadda TB; Shakya S; Pratama MRF; Das B; Biswas S; Jamalis J
Bioorg Chem; 2022 Feb; 119():105572. PubMed ID: 34971946
[TBL] [Abstract][Full Text] [Related]
15. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from
Merecz-Sadowska A; Isca VMS; Sitarek P; Kowalczyk T; Małecka M; Zajdel K; Zielińska-Bliźniewska H; Jęcek M; Rijo P; Zajdel R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674113
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from
Isca VMS; Sitarek P; Merecz-Sadowska A; Małecka M; Owczarek M; Wieczfińska J; Zajdel R; Nowak P; Rijo P; Kowalczyk T
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675627
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors.
Alam MJ; Alam O; Perwez A; Rizvi MA; Naim MJ; Naidu VGM; Imran M; Ghoneim MM; Alshehri S; Shakeel F
Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337078
[TBL] [Abstract][Full Text] [Related]
19.
Chowrasia D; Jafri A; Azad I; Rais J; Sharma N; Khan F; Kumar A; Kumar S; Arshad M
J Biomol Struct Dyn; 2022 Nov; 40(18):8569-8586. PubMed ID: 33955334
[TBL] [Abstract][Full Text] [Related]
20. Exploring α, β-unsaturated carbonyl compounds against bacterial efflux pumps
Dey S; Rathod S; Gumphalwad K; Yadav N; Choudhari P; Rajakumara E; Dhavale R; Mahuli D
J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37565744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
